← Leaderboards
Eric Meggers
University Of Pennsylvania
$3,788,212
Attributed
$3,788,212
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $768.4K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,788,212 · 2
By mechanism
P01$2,691,374 · 1
R01$1,096,838 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Ronen Marmorstein$40,497,435
- Meenhard Herlyn$50,214,821
- Gary A Molander$14,778,599
- Cecilia Tommos$3,587,309
- Ian Alexander Blair$30,276,296
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructurePlayNovel StrategiesScaffoldBinding (Molecular Function)Protein KinaseLeadMutationProtein Kinase InhibitorProtein Kinase InhibitorsStructure-Activity RelationshipComplexBiological FactorsCombinatorial ChemistryDesignInhibitor/AntagonistLigandsMetalsBraf GeneAmidesBiologicalApoptosisFamilyFeeding
Grant awards (10)
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity$575,790
P01 · FY2012 · CA · contact PI
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity$566,873
P01 · FY2011 · CA · contact PI
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity$611,248
P01 · FY2010 · CA · contact PI
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity$557,335
P01 · FY2009 · CA · contact PI
Metal Complexes as Protein Kinase Inhibitors$211,106
R01 · FY2009 · GM · contact PI
Development of Organometallic Protein Kinase Inhibitors with Anticancer Activity$380,128
P01 · FY2008 · CA · contact PI
Metal Complexes as Protein Kinase Inhibitors$211,106
R01 · FY2008 · GM · contact PI
Metal Complexes as Protein Kinase Inhibitors$211,470
R01 · FY2007 · GM · contact PI
Metal Complexes as Protein Kinase Inhibitors$218,148
R01 · FY2006 · GM · contact PI
Metal Complexes as Protein Kinase Inhibitors$245,008
R01 · FY2005 · GM